Macrophage- and lymphocyte-produced Th1 and Th2 cytokines in the tumour microenvironment

Research in Immunology

Volumn 149, Issue 7-8, 1998, Pages 651-653

  Fridman, W H ^a   Tartour, E ^a  

^a NONE

Author keywords

Cytokine; Macrophage; T lymphocyte; Review

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

CANCER IMMUNOLOGY; CONFERENCE PAPER; CYTOKINE PRODUCTION; HELPER CELL; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

EID: 0032322897     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80033-9     Document Type: Conference Paper

References (18)

1. Apostolopoulos, V., Xing, P.X. & McKenzie, I.F. (1994), Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens. Cancer Res., 54, 5186-93.
2. Blay, J.Y., Negrier, S., Combaret, V., Attali, S., Goillot, E., Mezrrouche, Y., Mercatello, A., Ravault, A., Tourani, J.M., Moskovtchenko, J.F., Philip, T. & Favrot, M. (1992), Serum levels of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res., 52, 3317.
3. Borysiewicz, L.K., Fiander, A., Nimako, M., Man, S., Wilkinson, G.W., Westmoreland, D., Evans, A.S., Adams, M., Stacey, S.N., Boursnell, M.E., Rutherford, E., Hickling, J.K. & Inglis, S.C. (1996), A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet, 347, 1523-1527.
4. Chen, L., Linsley, P.S. & Hellström, K.E. (1993), Costimulation of T cells for tumour immunity. Immunol. Today, 14, 483-486. (B7-098).
5. Fridman, W.H., Berger, A., Lee, R.S. & Tartour, E. (1998), Actualités en immunologie tumorale. Bull. Cancer, 85, 29-30.
6. Klein, B., Zhang, X.G., Lu, Z.Y. & Bataille, R. (1995), Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
7. Montera, F., Brailly, H., Sautès, C., Joyeux, I., Dorval, T., Mosseri, V., Yasukawa, K., Wijdenes, J., Adler, A., Gorin, I., Fridman, W.H. & Tartour, E. (1997), Characterization of soluble gp130 released by melanoma cell lines: a polyvalent antagonist of cytokines from IL-6 family. Clin. Cancer Res., 3, 1443-1451.
8. Nestle, P.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. & Schadendorf, D. (1998), Vaccination of melanoma patients with peptide-or tumour lysate-pulsed dendritic cells. Nature Med., 4, 328-333.
9. Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D., Seipp, C.A., Einhorn, J.H. & White, D.E. (1994), Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA, 271, 907-913.
10. Sastre-Garau, X., Loste, M.N., Vincent-Salomon, A., Favre, M., Mouret, E., de la Rochefordiere, A., Durand, J.C., Tartour, E., Lepage, V. & Charron, D. (1996), Decreased frequency of HLA-DRB1 13 alleles in French women with HPV-positive carcinoma of the cervix. Int. J. Cancer., 69, 159-164.
11. Schmidt-Wolf, G.D. & Schmidt-Wolf Ingo, G.H. (1995), Cytokines and gene therapy. Immunol. Today, 16, 173-175.
12. Tartour, E., Blay, J.Y., Dorval, T., Escudier, B., Mosseri, V., Douillard, J.Y., Deneux, L., Gorin, I., Negrier, S., Mathiot, C., Fouillart, P. & Fridman, W.H. (1996), Predictors of clinical response to interleukin-2-based immunotherapy in melanoma patients: a French multiinstitutional study. J. Clin. Oncol., 14, 1697-1703.
13. Tartour, E., Gey, A., Sastre-Garau, X., Lombard Surin, I., Mosseri, V. & Fridman, W.H. (1998a), Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J. Nat. Cancer Inst., 90, 287-294.
14. Tartour, E., Gey, A., Sastre-Garau, X., Pannetier, C., Mosseri, V., Kourilsky, P. & Fridman, W.H. (1994), Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res., 54, 6243-6248.
15. Tartour, E., Fossiez, F., Gey, A., Galinha, A., Joyeux, I., Lebecque, S., Fridman, W.H. & Sautès, C. (1998b), IL-17 a T cell derived cytokine which promotes the tumorigenicity of human cervical tumours in nude mice. American Association for Cancer Research (AACR ): New Orleans Abstract 4447.
16. Thiounn, N., Pages, F., Flam, T., Tartour, E., Mosseri, V., Zerbib, M., Beuzeboc, P., Deneux, L., Fridman, W.H. & Debre, B. (1997), IL-6 is a survival prognostic factor in renal cell carcinoma. Immunol. Lett., 58, 121-124.
17. Van Pel, A., van der Bruggen, P., Coulie, P.G., Brichard, V.G., Lethé, B., van den Eynde, B., Uyttenhove, C., Renauld, J.-C. & Boon, T. (1995), Genes coding for tumour antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145, 229-250.
18. Vitolo, D., Letessier, E.M., Johnson J.T. & Whiteside, T.L. (1992), Immunologic effector cells in head and neck cancer. J. Nat. Cancer Inst. Monographs, 13, 203-208.